Clinical Social Workers in Jarrettsville, MD Accepting Medicare
4 Clinical Social Workers found. Showing 1 - 4
 Ms. Ida Marie Henderson Sima, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1714 Jarrettsville Rd, North Harford Counseling, Llc, Jarrettsville, MD 21084 Phone: 443-613-6233 |
Gabrielle Mae Keen, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3803 Jarrettsville Pike, Jarrettsville, MD 21084 Phone: 410-459-6604 |
Rachel Lynn Kendzejeski, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1714 Jarrettsville Rd, Jarrettsville, MD 21084 Phone: 443-613-6233 |
Nicole Veronica Aranda, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 718 Norrisville Rd, Suite C, Jarrettsville, MD 21084 Phone: 410-692-5292 |
News Archive
Non-invasive brain stimulation may improve fine motor movement in stroke patients
Stroke is common and accompanied by complex disabilities-such as lower and upper limb disability, speech impairment, and chronic post-stroke pain.
Viewpoints: McKinsey report contentiousness; Medicare facts vs. beliefs; insurers' HSA 'strategy'
The White House routinely tries to intimidate its health-care critics, but the campaign against McKinsey & Co. is something else. The management consultants attempted to find out how U.S. business will respond to the government restructuring of 17.3% of the economy, Democrats don't like the results, and so McKinsey must pay with its reputation.
Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
› Verified 9 days ago
Pharmacists
Clinical Social Workers
Dentists
Counselors
Occupational Therapists